Chu Chieh Hsia

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. ncbi Quantification of hepatitis B virus genomes and infectivity in human serum samples
    Chu Chieh Hsia
    Division of Emerging and Transfusion Transmitted Diseases, CBER, FDA, Bethesda, Maryland, USA
    Transfusion 46:1829-35. 2006
  2. ncbi Microarray multiplex assay for the simultaneous detection and discrimination of hepatitis B, hepatitis C, and human immunodeficiency type-1 viruses in human blood samples
    Chu Chieh Hsia
    Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Review, Food and Drug Administration, Bethesda, MD 20892, USA
    Biochem Biophys Res Commun 356:1017-23. 2007
  3. ncbi Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection
    Robin Biswas
    Food and Drug Administration, Center for Biologics Evaluation and Research, Rockville, Maryland, USA
    Transfusion 43:788-98. 2003
  4. ncbi Truncated hepatitis C virus core protein encoded in hepatocellular carcinomas
    Rin Yamaguchi
    Division of Emerging and Transfusion Transmitted Diseases, Food and Drug Administration, Bethesda, MD 20852, USA
    Int J Mol Med 14:1097-100. 2004

Collaborators

Detail Information

Publications4

  1. ncbi Quantification of hepatitis B virus genomes and infectivity in human serum samples
    Chu Chieh Hsia
    Division of Emerging and Transfusion Transmitted Diseases, CBER, FDA, Bethesda, Maryland, USA
    Transfusion 46:1829-35. 2006
    ....
  2. ncbi Microarray multiplex assay for the simultaneous detection and discrimination of hepatitis B, hepatitis C, and human immunodeficiency type-1 viruses in human blood samples
    Chu Chieh Hsia
    Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Review, Food and Drug Administration, Bethesda, MD 20892, USA
    Biochem Biophys Res Commun 356:1017-23. 2007
    ..Our data represent a proof-of-concept for the possible use of highly sensitive multiplex microarray assay to screen and confirm the presence of these viruses in blood donors and patients...
  3. ncbi Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection
    Robin Biswas
    Food and Drug Administration, Center for Biologics Evaluation and Research, Rockville, Maryland, USA
    Transfusion 43:788-98. 2003
    ..Single-sample NAT would increase yield by 13 to 15 units per 107 donations over pooled-sample NAT and newer HBsAg assays and by 35 to 50 units per 107 donations over currently licensed HBsAg assays...
  4. ncbi Truncated hepatitis C virus core protein encoded in hepatocellular carcinomas
    Rin Yamaguchi
    Division of Emerging and Transfusion Transmitted Diseases, Food and Drug Administration, Bethesda, MD 20852, USA
    Int J Mol Med 14:1097-100. 2004
    ....